Literature DB >> 11477585

Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.

P Wyss1, V Schwarz, D Dobler-Girdziunaite, R Hornung, H Walt, A Degen, M Fehr.   

Abstract

Chest wall recurrences are a frequent problem in patients treated by mastectomy for breast cancer. Surgery and ionizing radiation are established treatment modalities in these cases. Photodynamic therapy (PDT) provides an alternative treatment modality using a photosensitizer and laser light to induce selective tumor necrosis. PDT was performed as compassionate use in 7 patients aged 57.6 years (+/-12.6 SD). A total of 89 metastatic skin nodes were treated in 11 PDT sessions. As photosensitizer meta-tetra(hydroxyphenyl)chlorin (m-THPC) was applied intravenously. Patients (n = 3) photosensitized with a drug dose of 0.10 mg/kg bodyweight were irradiated 48 hr after drug application at a lightdose of 5 J/cm(2). Patients (n = 4) were illuminated by an optical dose of 10 J/cm(2) 96 hr after photosensitization with 0.15 mg/kg. Laser light at a wavelength of 652 nm was generated by a diode laser and applied by a front lens light diffuser using a fluence rate of 20--25 mW/cm(2). PDT using m-THPC resulted in complete response in all patients. Response to treatment did not differ when using the 2 different drugdose protocols. Healing time depended mainly on the size of the illumination field but not on the lightdose. Pain score usually raised 1 day after PDT and lasted at higher levels for about 10 days. Healing time usually ranged between 8--10 weeks. Photodynamic technique offers a minimal-invasive, outpatient treatment modality for recurrent breast cancer on the chest wall with few side effects, high patient's satisfaction and with possible repetitive application. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477585     DOI: 10.1002/ijc.1400

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

2.  TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.

Authors:  Yihui Chen; Munawwar Sajjad; Yanfang Wang; Carrie Batt; Hani A Nabi; Ravindra K Pandey
Journal:  ACS Med Chem Lett       Date:  2010-11-23       Impact factor: 4.345

3.  Photodynamic therapy for breast cancer in a BALB/c mouse model.

Authors:  Tae-Gyu Ahn; Byoung-Rai Lee; Eun-Young Choi; Dong Won Kim; Sei-Jun Han
Journal:  J Gynecol Oncol       Date:  2012-04-03       Impact factor: 4.401

4.  Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.

Authors:  Zhong-sheng Tong; Pei-tian Miao; Ting-ting Liu; Yong-sheng Jia; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

5.  Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer.

Authors:  Wenqing G Sun; Christine J Weydert; Yuping Zhang; Lei Yu; Jingru Liu; Douglas R Spitz; Joseph J Cullen; Larry W Oberley
Journal:  Cancers (Basel)       Date:  2010-02-12       Impact factor: 6.639

Review 6.  Antibody-based imaging strategies for cancer.

Authors:  Jason M Warram; Esther de Boer; Anna G Sorace; Thomas K Chung; Hyunki Kim; Rick G Pleijhuis; Gooitzen M van Dam; Eben L Rosenthal
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.

Authors:  Timothy James Kinsella; Elma D Baron; Valdir C Colussi; Kevin D Cooper; Charles L Hoppel; Stephen T Ingalls; Malcolm E Kenney; Xiaolin Li; Nancy L Oleinick; Seth R Stevens; Scot C Remick
Journal:  Front Oncol       Date:  2011-06-30       Impact factor: 6.244

8.  Treatment of canine osseous tumors with photodynamic therapy: a pilot study.

Authors:  S Burch; C London; B Seguin; C Rodriguez; B C Wilson; S K Bisland
Journal:  Clin Orthop Relat Res       Date:  2009-01-22       Impact factor: 4.176

9.  Photodynamic therapy for gynecological diseases and breast cancer.

Authors:  Natashis Shishkova; Olga Kuznetsova; Temirbolat Berezov
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

10.  Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells.

Authors:  M-H Teiten; L Bezdetnaya; P Morlière; R Santus; F Guillemin
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.